Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Shapiro

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibodyAnton Y Peleg, Shahid Husain, Eun J Kwak, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 11, 2012
Rates and correlates of health maintenance behaviors after living kidney donationLarissa Myaskovsky, Donna Almario Doebler, Donna M Posluszny, et al.
Clinical Transplantation|February 24, 2024
Do pre-transplant cultural factors predict health-related quality of life after kidney transplantation?Jamie M Loor, C Graham Ford, Yuridia Leyva, et al.
The Journal of Pediatrics|June 14, 2006
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantationRon Shapiro, Demetrius Ellis, Henkie P Tan, et al.
Journal of the American College of Surgeons|April 5, 2005
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or CampathRon Shapiro, Amit Basu, Henkie Tan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trialsBernd Schröppel, Enver Akalin, Mukta Baweja, et al.
Annals of Surgery|October 8, 2003
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaningRon Shapiro, Mark L Jordan, Amit Basu, et al.
Transplantation Proceedings|November 2, 2025
Understanding Decision Making and Post-Donation Experiences for Robotic Single Port and Laparoscopic Donor NephrectomyDaniel Wang, Christopher Connors, Juan Sebastian Arroyave Villada, et al.
Clinical Transplantation|March 8, 2017
Early conversion to belatacept after renal transplantationVinay Nair, Luz Liriano-Ward, Rebecca Kent, et al.
Transplantation|February 21, 2012
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantationCamila Macedo, John T Walters, Elizabeth A Orkis, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibodyAnton Y Peleg, Shahid Husain, Eun J Kwak, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 11, 2012
Rates and correlates of health maintenance behaviors after living kidney donationLarissa Myaskovsky, Donna Almario Doebler, Donna M Posluszny, et al.
Clinical Transplantation|February 24, 2024
Do pre-transplant cultural factors predict health-related quality of life after kidney transplantation?Jamie M Loor, C Graham Ford, Yuridia Leyva, et al.
The Journal of Pediatrics|June 14, 2006
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantationRon Shapiro, Demetrius Ellis, Henkie P Tan, et al.
Journal of the American College of Surgeons|April 5, 2005
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or CampathRon Shapiro, Amit Basu, Henkie Tan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trialsBernd Schröppel, Enver Akalin, Mukta Baweja, et al.
Annals of Surgery|October 8, 2003
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaningRon Shapiro, Mark L Jordan, Amit Basu, et al.
Transplantation Proceedings|November 2, 2025
Understanding Decision Making and Post-Donation Experiences for Robotic Single Port and Laparoscopic Donor NephrectomyDaniel Wang, Christopher Connors, Juan Sebastian Arroyave Villada, et al.
Clinical Transplantation|March 8, 2017
Early conversion to belatacept after renal transplantationVinay Nair, Luz Liriano-Ward, Rebecca Kent, et al.
Transplantation|February 21, 2012
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantationCamila Macedo, John T Walters, Elizabeth A Orkis, et al.
Pageof 23